Pei Zhang
BGI Group (China)(CN)Nanjing University of Chinese Medicine(CN)Ministry of Education of the People's Republic of China(CN)China Pharmaceutical University(CN)Beijing Technology and Business University(CN)Tianjin University of Finance and Economics(CN)Andrew McDonough B+ Foundation(US)Jiangning District of Nanjing Chinese Medicine Hospital(CN)Second Affiliated Hospital of Nanjing Medical University(CN)Berlin Institute of Health at Charité - Universitätsmedizin Berlin(DE)Nanjing Jiangning Hospital(CN)Charité - Universitätsmedizin Berlin(DE)Charité - Universitätsmedizin Berlin(DE)Analysis Group (United States)(US)
Publications by Year
Research Areas
Metabolomics and Mass Spectrometry Studies, Advanced biosensing and bioanalysis techniques, Mass Spectrometry Techniques and Applications, Gut microbiota and health, Adenosine and Purinergic Signaling
Most-Cited Works
- → Epigenetic modification and inheritance in sexual reversal of fish(2014)435 cited
- → Challenges, progress and promises of metabolite annotation for LC–MS-based metabolomics(2018)353 cited
- → Defining the Scope of Exposome Studies and Research Needs from a Multidisciplinary Perspective(2021)145 cited
- → Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response(2020)97 cited
- → Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma(2022)95 cited
- → Microplastic-mediated new mechanism of liver damage: From the perspective of the gut-liver axis(2024)91 cited